Old and new tools to assess dyspnea in the hospitalized patient (Q38114009)

29 August 2017

title

Old and new tools to assess dyspnea in the hospitalized patient (English)

1 reference

29 August 2017

Barbro Kjellström

1 reference

29 August 2017

Martje H L van der Wal

series ordinal

1 reference

29 August 2017

publication date

1 September 2013

1 reference

Current heart failure reports

29 August 2017

published in

1 reference

29 August 2017

1 reference

29 August 2017

1 reference

29 August 2017

page(s)

204-211

1 reference

Aliskiren, ALTITUDE, and the implications for ATMOSPHERE.

29 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0141-0

The experience of living with chronic heart failure: a narrative review of qualitative studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0141-0

Symptom variability, not severity, predicts rehospitalization and mortality in patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0141-0

Physical and emotional symptom burden of patients with end-stage heart failure: what to measure, how and why.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0141-0

Dyspnoea and worsening heart failure in patients with acute heart failure: results from the Pre-RELAX-AHF study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0141-0

Impact of symptom prevalence and symptom burden on quality of life in patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0141-0

The worst symptom as defined by patients during heart failure hospitalization: implications for response to therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0141-0

An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0141-0

Cardiopulmonary interaction in heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0141-0

Skeletal muscle abnormalities and evidence for their role in symptom generation in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0141-0

Changes in the amplitude of electrocardiogram QRS complexes during follow-up of heart failure patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0141-0

The diagnostic utility of brain natriuretic peptide in heart failure patients presenting with acute dyspnea: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0141-0

Quantifying the added value of BNP in suspected heart failure in general practice: an individual patient data meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0141-0

Natriuretic peptides (BNP and NT-proBNP): measurement and relevance in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0141-0

Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0141-0

Diagnostic accuracy of BNP and NT-proBNP in patients presenting to acute care settings with dyspnea: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0141-0

Natriuretic peptide-guided therapy in chronic heart failure: a meta-analysis of 2,686 patients in 12 randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0141-0

Brain natriuretic peptide-guided therapy in the inpatient management of decompensated heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0141-0

Cardiac electronic implantable devices in the treatment of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0141-0

Review of advanced heart failure device diagnostics examined in clinical trials and the potential benefit from monitoring capabilities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0141-0

Burden of atrial fibrillation and poor rate control detected by continuous monitoring and the risk for heart failure hospitalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0141-0

Combined heart failure device diagnostics identify patients at higher risk of subsequent heart failure hospitalizations: results from PARTNERS HF (Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients Wit

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0141-0

Development and validation of an integrated diagnostic algorithm derived from parameters monitored in implantable devices for identifying patients at risk for heart failure hospitalization in an ambulatory setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0141-0

Sensitivity and positive predictive value of implantable intrathoracic impedance monitoring as a predictor of heart failure hospitalizations: the SENSE-HF trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0141-0

Intrathoracic impedance monitoring, audible patient alerts, and outcome in patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0141-0

21 January 2018

Dyspnoea and the brain.

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0141-0

Utility approach to measuring health-related quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0141-0

Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0141-0

The impact of early standard therapy on dyspnoea in patients with acute heart failure: the URGENT-dyspnoea study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0141-0

Improvements in signs and symptoms during hospitalization for acute heart failure follow different patterns and depend on the measurement scales used: an international, prospective registry to evaluate the evolution of measures of disease severity i

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0141-0

The significance of respiratory symptoms and the diagnosis of chronic bronchitis in a working population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0141-0

Understanding dyspnoea by its language

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0141-0

The language of breathlessness. Use of verbal descriptors by patients with cardiopulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0141-0

Distinguishable types of dyspnea in patients with shortness of breath

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0141-0

Validation of a three-factor measurement model of dyspnea in hospitalized adults with heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0141-0

Reliability and validity of dyspnea sensory quality descriptors in heart failure patients treated in an emergency department.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0141-0

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0141-0

Minimally clinically important difference in chronic breathlessness: every little helps

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0141-0

Measuring the dyspnea of decompensated heart failure with a visual analog scale: how much improvement is meaningful?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0141-0

Reliability and validity of the multidimensional dyspnea profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0141-0

Test-retest reliability of multidimensional dyspnea profile recall ratings in the emergency department: a prospective, longitudinal study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0141-0

The affective dimension of laboratory dyspnea: air hunger is more unpleasant than work/effort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0141-0

Measuring shortness of breath in heart failure (SOB‐HF): development and validation of a new dyspnoea assessment tool

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0141-0

The clinical diagnosis of pulmonary emphysema; an experimental study

21 January 2018

1 reference

12 December 2020

Myocardial and systemic iron depletion in heart failure implications for anemia accompanying heart failure

1 reference

12 December 2020

Why Recording of an Electrocardiogram Should be Required in Every Inpatient and Outpatient Encounter of Patients with Heart Failure

1 reference

12 December 2020

Causes and evaluation of chronic dyspnea.

1 reference

12 December 2020

Disordered iron homeostasis in chronic heart failure: prevalence, predictors, and relation to anemia, exercise capacity, and survival

1 reference

12 December 2020

Reasons for seeking acute care in chronic heart failure

1 reference

12 December 2020

Changes in dyspnea-fatigue ratings as indicators of quality of life in the treatment of congestive heart failure

1 reference

12 December 2020

Symptoms experienced in the last six months of life in patients with end-stage heart failure

1 reference

12 December 2020

BOLD fMRI identifies limbic, paralimbic, and cerebellar activation during air hunger

1 reference

12 December 2020

ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the

1 reference

12 December 2020

Slow breathing reduces chemoreflex response to hypoxia and hypercapnia, and increases baroreflex sensitivity

1 reference

12 December 2020

Multicenter prospective investigation on efficacy and safety of carperitide as a first-line drug for acute heart failure syndrome with preserved blood pressure: COMPASS: Carperitide Effects Observed Through Monitoring Dyspnea in Acute Decompensated

1 reference

12 December 2020

The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes

1 reference

12 December 2020

Improvement in exercise tolerance and symptoms of congestive heart failure during treatment with candesartan cilexetil. Symptom, Tolerability, Response to Exercise Trial of Candesartan Cilexetil in Heart Failure (STRETCH) Investigators

1 reference

12 December 2020

Effects of a home walking exercise program on functional status and symptoms in heart failure

1 reference

12 December 2020

Comparative effects of losartan and enalapril on exercise capacity and clinical status in patients with heart failure. The Losartan Pilot Exercise Study Investigators

1 reference

12 December 2020

Predictors and effect of physical symptom status on health-related quality of life in patients with heart failure

1 reference

12 December 2020

Anaemia among patients with heart failure and preserved or reduced ejection fraction: results from the SENIORS study

1 reference

12 December 2020

Closing capacity and gas exchange in chronic heart failure

1 reference

12 December 2020

10.1007/S11897-013-0141-0

Identifiers

DOI

1 reference

Dimensions Publication ID

29 August 2017

1043491720

0 references

Fatcat ID

release_yklsf7376zeetpgovsqcss4jrm

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/yklsf7376zeetpgovsqcss4jrm

24 November 2022

mapped directly with Wikidata item

1 reference